"Trojan Horse" DNA Nanostructure for Personalized Theranostics : Can It Knock on the Door of Preclinical Practice?
Nanotheranostics, combing diagnostic and therapeutic components in an all-in-one nanomaterial, possess exciting potentials for precision nanomedicine. However, a major obstacle for current nanotheranostics to enter preclinical and/or clinical trials is the intrinsic toxicities of these nanomaterials...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Langmuir : the ACS journal of surfaces and colloids. - 1992. - 34(2018), 49 vom: 11. Dez., Seite 15028-15044
|
1. Verfasser: |
Li, Yuan
(VerfasserIn) |
Weitere Verfasser: |
Yang, Sheng,
Zheng, Jing,
Zou, Zhen,
Yang, Ronghua,
Tan, Weihong |
Format: | Online-Aufsatz
|
Sprache: | English |
Veröffentlicht: |
2018
|
Zugriff auf das übergeordnete Werk: | Langmuir : the ACS journal of surfaces and colloids
|
Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Antineoplastic Agents
Drug Carriers
DNA
9007-49-2 |